Pegfilgrastim is a medication used to reduce the risk of infection in patients undergoing chemotherapy for certain types of cancer. It is prescribed to stimulate the production of white blood cells in the body, helping to prevent infections that may occur as a side effect of chemotherapy treatment.
Reduction In Duration Of Neutropenia And Incidence Of Febrile Neutropenia In Cytotoxic Chemotherapy For Malignancy:
By Sc Inj:
Adult: 6 Mg For Each Chemotherapy Cycle, To Be Started At Least 24 Hours After Chemotherapy.
Children: Not Recommended.
Content
Inj 6mg: Per 0.6 ml: Pegfilgrastim 6mg; Pre-Filled Syringes.
Pregnancy
Risk Cannot Be Ruled Out, Use Only If Extremely Necessary.
Stability
Recombinant G-csf (recombinant Human Granulocyte-colony Stimulating Factor)
Contra Indications
Hypersensitivity To E. Coli Derived Proteins, Secondary Acute Or Chronic Leukaemia, Myelodysplastic Syndrome.
Precautions
Hypersensitivity To E. Coli Derived Proteins, Secondary Acute Or Chronic Leukaemia, Myelodysplastic Syndrome.